{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:23:09Z","timestamp":1790716989887,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0148891","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T19:02:07Z","timestamp":1455303727000},"page":"e0148891","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Association of PON1, P2Y12 and COX1 with Recurrent Ischemic Events in Patients with Extracranial or Intracranial Stenting"],"prefix":"10.1371","volume":"11","author":[{"given":"Xiao-Qing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Sen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Peng","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Gang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Quan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Rong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jaad.2014.10.027","article-title":"A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons","volume":"72","author":"DG Brown","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1747-4949.2012.00828.x","article-title":"The effectiveness of dual antiplatelet treatment in acute ischemic stroke patients with intracranial arterial stenosis: a subgroup analysis of CLAIR study","volume":"8","author":"X Wang","year":"2013","journal-title":"Int J Stroke"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/STROKEAHA.111.637686","article-title":"Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials","volume":"43","author":"CM Geeganage","year":"2012","journal-title":"Stroke"},{"issue":"14","key":"ref4","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"DJ Angiolillo","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","article-title":"Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study","volume":"46","author":"PA Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacc.2006.10.050","article-title":"Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?","volume":"49","author":"KP Bliden","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jacc.2012.11.040","article-title":"Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in platelet function","volume":"61","author":"AL Frelinger 3rd","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3 Suppl","key":"ref8","doi-asserted-by":"crossref","first-page":"27A","DOI":"10.1016\/j.amjcard.2008.11.020","article-title":"Variability in responsiveness to oral antiplatelet therapy","volume":"103","author":"DJ Angiolillo","year":"2009","journal-title":"Am J Cardiol"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"JL Mega","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","article-title":"Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects","volume":"116","author":"M Ingelman-Sundberg","year":"2007","journal-title":"Pharmacol Ther"},{"key":"ref11","article-title":"Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics","author":"MG Mooij","year":"2015","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"e55197","DOI":"10.1371\/journal.pone.0055197","article-title":"ABCB1 variation and treatment response in AIDS patients: initial results of the Henan cohort","volume":"8","author":"P Zhu","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nm.2281","article-title":"Paraoxonase-1 is a major determinant of clopidogrel efficacy","volume":"17","author":"HJ Bouman","year":"2011","journal-title":"Nat Med"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy","volume":"302","author":"AR Shuldiner","year":"2009","journal-title":"JAMA"},{"issue":"Suppl 2","key":"ref15","first-page":"29","article-title":"Pharmacokinetic profile of 14C-labeled clopidogrel","volume":"25","author":"R Lins","year":"1999","journal-title":"Semin Thromb Hemost"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2174\/138161206776361318","article-title":"Biology and pharmacology of the platelet P2Y12 receptor","volume":"12","author":"RF Storey","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/nn1805","article-title":"The P2Y12 receptor regulates microglial activation by extracellular nucleotides","volume":"9","author":"SE Haynes","year":"2006","journal-title":"Nat Neurosci"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3109\/00207454.2013.798733","article-title":"Effects of uncoupling protein 2 -866G\/A polymorphism on platelet reactivity and prognosis in Chinese patients with type 2 diabetes and ischemic stroke","volume":"123","author":"Y Chai","year":"2013","journal-title":"Int J Neurosci"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614133","article-title":"Identification and biological activity of the active metabolite of clopidogrel","volume":"84","author":"P Savi","year":"2000","journal-title":"Thromb Haemost"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/dmd.31.1.53","article-title":"The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin","volume":"31","author":"TA Clarke","year":"2003","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.clpt.6100139","article-title":"Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently","volume":"81","author":"NA Farid","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0306-3623(98)00028-7","article-title":"Human serum paraoxonase","volume":"31","author":"B Mackness","year":"1998","journal-title":"Gen Pharmacol"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1538-7836.2011.04457.x","article-title":"Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention","volume":"9","author":"G Campo","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijcard.2012.08.017","article-title":"Besides CYP2C19, PON1 genetic variant influences post-clopidogrel platelet reactivity in Chinese patients","volume":"165","author":"H Wu","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"e52779","DOI":"10.1371\/journal.pone.0052779","article-title":"Paraoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCI","volume":"8","author":"KW Park","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/FPC.0000000000000035","article-title":"The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease","volume":"24","author":"C Xie","year":"2014","journal-title":"Pharmacogenet Genomics"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"e110188","DOI":"10.1371\/journal.pone.0110188","article-title":"Effects of cytochrome P450 2C19 and paraoxonase 1 polymorphisms on antiplatelet response to clopidogrel therapy in patients with coronary artery disease","volume":"9","author":"D Tresukosol","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jcin.2013.06.010","article-title":"Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease","volume":"6","author":"C Viviani Anselmi","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.thromres.2013.05.006","article-title":"Genetic determinants of high on-treatment platelet reactivity in clopidogrel treated Chinese patients","volume":"132","author":"L Zhang","year":"2013","journal-title":"Thromb Res"},{"issue":"6817","key":"ref30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"G Hollopeter","year":"2001","journal-title":"Nature"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.CIR.0000085073.69189.88","article-title":"Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects","volume":"108","author":"P Fontana","year":"2003","journal-title":"Circulation"},{"issue":"24","key":"ref32","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1161\/01.CIR.0000106904.80795.35","article-title":"P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study","volume":"108","author":"P Fontana","year":"2003","journal-title":"Circulation"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2350-8-59","article-title":"Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease","volume":"8","author":"U Cavallari","year":"2007","journal-title":"BMC Med Genet"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.thromres.2007.01.012","article-title":"Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome","volume":"120","author":"T Cuisset","year":"2007","journal-title":"Thromb Res"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.gene.2014.06.023","article-title":"Impacts of COX-1 gene polymorphisms on vascular outcomes in patients with ischemic stroke and treated with aspirin","volume":"546","author":"L Cao","year":"2014","journal-title":"Gene"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000342489","article-title":"Frequency, risk factors, prognosis, and genetic polymorphism of the cyclooxygenase-1 gene for aspirin resistance in elderly Chinese patients with cardiovascular disease","volume":"59","author":"L Fan","year":"2013","journal-title":"Gerontology"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/1076029612444002","article-title":"Genetic polymorphisms of HO-1 and COX-1 are associated with aspirin resistance defined by light transmittance aggregation in Chinese Han patients","volume":"19","author":"XL Li","year":"2013","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0026-895X(25)09788-3","article-title":"Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese","volume":"46","author":"SM De Morais","year":"1994","journal-title":"Mol Pharmacol"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clpt.2005.10.002","article-title":"A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants","volume":"79","author":"SC Sim","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.clpt.6100291","article-title":"Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients","volume":"83","author":"I Rudberg","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCULATIONAHA.109.885194","article-title":"Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement","volume":"121","author":"D Sibbing","year":"2010","journal-title":"Circulation"},{"issue":"22","key":"ref42","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1016\/S0021-9258(17)40694-6","article-title":"The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans","volume":"269","author":"SM de Morais","year":"1994","journal-title":"J Biol Chem"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/hrt.2011.227272","article-title":"Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents","volume":"98","author":"IY Oh","year":"2012","journal-title":"Heart"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/clpt.2011.221","article-title":"Predicting clopidogrel response using DNA samples linked to an electronic health record","volume":"91","author":"JT Delaney","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/FPC.0b013e328359253a","article-title":"Effects of CYP2C19 variant alleles on postclopidogrel platelet reactivity and clinical outcomes in an actual clinical setting in China","volume":"22","author":"H Wu","year":"2012","journal-title":"Pharmacogenet Genomics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0148891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T11:01:31Z","timestamp":1748775691000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0148891"}},"subtitle":[],"editor":[{"given":"Jens","family":"Minnerup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0148891","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]}}}